Yet, when combined with the GLUT1 inhibitor Bay-876, inhibition of cancer cell growth was seen, demonstrating a potential combined role of glycolysis and glutaminolysis in cancer cell growth [32]. The gene discussed is SLC2A1; the disease is cancer.